Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. Tezepelumab blocks thymic stromal lymphopoietin...
15 KB (1,017 words) - 06:45, 3 March 2024
November. In December, the FDA approved Amgen and AstraZeneca's Tezspire (tezepelumab) for severe asthma. The FDA also approved Amgen's Otezla for adults with...
96 KB (7,736 words) - 20:56, 28 August 2024
allergy shots and a monoclonal antibody Tezepelumab. Among the tests, the participants given the shot with the Tezepelumab had greater results than the placebo...
23 KB (2,405 words) - 13:34, 24 August 2024
lymphoma". Anticancer Research. 33 (1): 85–95. PMID 23267131. "Tezspire- tezepelumab-ekko injection, solution". DailyMed. 17 December 2021. Archived from...
136 KB (4,020 words) - 07:14, 15 August 2024
24 May 2009. "Tezspire- tezepelumab-ekko injection, solution". DailyMed. Retrieved 24 December 2021. "Tezspire (tezepelumab) approved in the US for severe...
23 KB (2,415 words) - 21:50, 4 February 2024
Oxelumab§ Pamrevlumab Placulumab Relatlimab† Sarilumab Sifalimumab Tabalumab Tezepelumab Ulocuplumab Varlilumab Immune activation: Ipilimumab Durvalumab Nivolumab...
38 KB (4,316 words) - 10:24, 26 August 2024
R03DX08 Reslizumab R03DX09 Mepolizumab R03DX10 Benralizumab R03DX11 Tezepelumab "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis"...
6 KB (571 words) - 11:23, 14 March 2024
include omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab. Omalizumab binds to free human immunoglobulin (IgE) to reduce IgE level...
26 KB (2,749 words) - 01:59, 28 July 2024
Oxelumab§ Pamrevlumab Placulumab Relatlimab† Sarilumab Sifalimumab Tabalumab Tezepelumab Ulocuplumab Varlilumab Immune activation: Ipilimumab Durvalumab Nivolumab...
2 KB (87 words) - 01:28, 30 May 2023